Women treated for gynaecological cancer perceive many difficulties in life on the personal, social, and physical levels. Today they are offered a 3 to 5 year follow-up programme at the hospital where the main purpose is to improve survival. However, the women are very nervous before follow-up visits and although they feel safe about them, they express that their needs of psychosocial care and self-management support are not fulfilled. The proposed study will test a person-centred intervention tailored the women's needs in a randomised controlled trial. The intervention will be based on the method Guided Self Determination (GSD), which has proved able to realize empowerment in practice in relationships between patients and healthcare professionals. GSD involves systematic use of condition-adjusted worksheets ('reflection sheets'), and advanced professional communication. Using reflection sheets filled out by each woman as the starting point for communication, problem solving will be tailored her personal needs. We expect that the intervention has the potential to support the women in better managing specific complications and difficulties related to concerns about recovery, body perception, fertility and establishment of intimate relations with their partner, all aspects important for the women's quality of life in the follow-up period after cancer diagnosis and treatment. The study will be the first to test GSD in cancer patients.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
165
Gynaecological Department, Juliane Marie Centret,Copenhagen University Hospital Rigshospitalet
Copenhagen, Copenhagen Ø, Denmark
Primary Outcome: Quality of life measured by the scale Quality of life- Cancer Survivors (QOL-CS)
+/- one week for practical reasons
Time frame: 9 months after randomisation
Quality of Life measured by the scale Quality of Life Cancer Survivors- (QOL-CS)
+/- one week for practical reasons
Time frame: 3 months after randomisation
Changes in Quality of life in the two groups
Quality of life at 9 months minus the quality of life at the time of randomisation.
Time frame: 9 months
Positive and negative impact of cancer measured by Impact of Cancer version 2 (IOCv2)
+/- one week for practical reasons
Time frame: 3 and 9 months after randomisation
Self-esteem measured by Rosenbergs Self Esteem Scale
+/- one week for practical reasons
Time frame: 3 and 9 months after randomisation
Anxiety and depression measured by Hospital Anxiety and Depression Scale (HADS)
Also used as screening instrument baseline. +/- one week for practical reasons
Time frame: 3 and 9 months from randomisation
Autonomy-supportive relationship between patient and health care professionals measured by Health Care Climate Questionnaire (HCCQ)
+/- one week for practical reasons
Time frame: 3 and 9 months from randomisation
Distress measured by Distress Thermometer(DT).
Also used as screening instrument baseline. +/- one week for practical reasons.
Time frame: 3 and 9 months from randomisation
Symptom monitoring and recognition
Womens ability to know what symptoms to monitor and react to in case of recurrence
Time frame: 3 and 9 months after randomisation (+/- one week for practical reasons)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.